Denis Naughten
Ceist:441. Deputy Denis Naughten asked the Minister for Health the reason Pioglitazone remains an approved drug under the GMS for the treatment of diabetes in view of the fact that the US Food and Drug Administration has found it to be associated with bladder tumours; and if he will make a statement on the matter. [4367/19]
Amharc ar fhreagra